UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 424

Sortiert nach

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

Annals of oncology, 2011-04, Vol.22 (4), p.787-793

2011

Volltextzugriff (PDF)

Phase II trial of imatinib mesylate in patients with metastatic melanoma

British journal of cancer, 2008-09, Vol.99 (5), p.734-740

2008

Volltextzugriff (PDF)

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1752-1759

1998

Volltextzugriff (PDF)

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.529-538.e13

2018

Volltextzugriff (PDF)

Prognostic factors for survival of patients treated systemically for disseminated melanoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1103-1111

1998

Volltextzugriff (PDF)

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1039-1051

1997

Volltextzugriff (PDF)

Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors

Cancer, 1995-11, Vol.76 (9), p.1665-1670

1995

Volltextzugriff (PDF)

Uveal melanoma: natural history and treatment options for metastatic disease

Melanoma research, 1999-12, Vol.9 (6), p.575-582

1999

Volltextzugriff (PDF)

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-α

Annals of oncology, 1996-10, Vol.7 (8), p.827-835

1996

Volltextzugriff (PDF)

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2895-2899

1995

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Clinical cancer research, 2002-05, Vol.8 (5), p.1038-1044

2002

Volltextzugriff (PDF)

Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis

Clinical therapeutics, 2011-10, Vol.33 (10), p.1537-1546

2011

Volltextzugriff (PDF)

Phase II evaluation of bryostatin-1 in metastatic melanoma

Melanoma research, 2001-04, Vol.11 (2), p.183-188

2001

Volltextzugriff (PDF)

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Melanoma research, 2012-08, Vol.22 (4), p.310-315

2012

Volltextzugriff (PDF)

The Death of Mourning: From Victorian Crepe to the Little Black Dress

Omega: Journal of Death and Dying, 2008-01, Vol.57 (1), p.35-52

Bedikian, Sonia A.

2008

Volltextzugriff (PDF)

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

Annals of oncology, 1997-04, Vol.8 (4), p.363-368

1997

Volltextzugriff (PDF)

Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma

Clinical cancer research, 1998-03, Vol.4 (3), p.619-627

1998

Volltextzugriff (PDF)

Pharmacokinetics of meropenem in patients with intra-abdominal infections

Antimicrobial Agents and Chemotherapy, 1994-01, Vol.38 (1), p.151-154

1994

Volltextzugriff (PDF)

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

Oncology reports, 1999-09, Vol.6 (5), p.1097

1999

Volltextzugriff (PDF)

1126P - Phase II Study of Ipilimumab Plus Temozolomide in Patients with Metastatic Melanoma

Annals of oncology, 2012-09, Vol.23, p.ix366-ix367

2012

Volltextzugriff (PDF)

Increased Incidence of Renal Cell Carcinoma (RCC) Among Melanoma Patients

Annals of oncology, 2012-09, Vol.23, p.ix454

2012

Volltextzugriff (PDF)

Phase II Study of Ipilimumab Plus Temozolomide in Patients with Metastatic Melanoma

Annals of oncology, 2012-09, Vol.23, p.ix366-ix367

2012

Volltextzugriff (PDF)

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma

Anti-cancer drugs, 2002-02, Vol.13 (2), p.169-172

2002

Volltextzugriff (PDF)

Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

Melanoma research, 1998-12, Vol.8 (6), p.549-556

1998

Volltextzugriff (PDF)

A Phase 2 Randomized Study of Ramucirumab (IMC 1121B; RAM) with or Without Dacarbazine (DTIC) in Patients (PTS) with Metastatic Melanoma (MM) (CP12-0604/NCT00533702)

Annals of oncology, 2012-09, Vol.23, p.ix363

2012

Volltextzugriff (PDF)

1 – 25 von 424

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(392)
Mit Volltextzugriff
(394)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(263)
Humans
(156)
Life Sciences & Biomedicine
(146)
Physics
(125)
Male
(123)
Female
(122)
Oncology
(122)
Middle Aged
(120)
Physical Sciences
(117)
Adult
(115)
Physics, Particles & Fields
(108)
Aged
(106)
Astronomy & Astrophysics
(68)
Melanoma - Drug Therapy
(61)
Physics, Nuclear
(57)
Biological And Medical Sciences
(56)
Medical Sciences
(56)
Physics Of Elementary Particles And Fields
(55)
Melanoma
(46)
Dermatology
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

Phase II trial of imatinib mesylate in patients with metastatic melanoma

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

Prognostic factors for survival of patients treated systemically for disseminated melanoma

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors

Uveal melanoma: natural history and treatment options for metastatic disease

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-α

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis

Phase II evaluation of bryostatin-1 in metastatic melanoma

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

The Death of Mourning: From Victorian Crepe to the Little Black Dress

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma

Pharmacokinetics of meropenem in patients with intra-abdominal infections

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

1126P - Phase II Study of Ipilimumab Plus Temozolomide in Patients with Metastatic Melanoma

Increased Incidence of Renal Cell Carcinoma (RCC) Among Melanoma Patients

Phase II Study of Ipilimumab Plus Temozolomide in Patients with Metastatic Melanoma

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma

Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

A Phase 2 Randomized Study of Ramucirumab (IMC 1121B; RAM) with or Without Dacarbazine (DTIC) in Patients (PTS) with Metastatic Melanoma (MM) (CP12-0604/NCT00533702)

Suchergebnisse filtern